SCHEMBL25553231

SCHEMBL25553231

COC[C@H]1O[C@@H](C)C(OC)[C@H]1OP(=O)(O)OC[C@H]1O[C@@H](C)C(F)[C@H]1OP(=O)(O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13882147 0.94 FBP1 (0.30) —
SCHEMBL13882144 0.93 FBP1 (0.31) —
SCHEMBL25553232 0.89 FBP1 (0.30) —
SCHEMBL25572011 0.89 — —
SCHEMBL25572013 0.88 — —
SCHEMBL20465720 0.88 — —
SCHEMBL12128761 0.86 FBP1 (0.33) —
SCHEMBL13882141 0.82 FBP1 (0.33) —
SCHEMBL26040764 0.82 FBP1 (0.42) —
SCHEMBL24211073 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158059-A1 PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF ADARX PHARMACEUTICALS, INC. (US) 2023-05-25 — — US disclosed
Send feedback